Post by Zanteris

One of the most common mistakes in clinical research ? Involving the biostatistician too late. Too often, statistical expertise is seen as something required “once the data are ready.” But by then, critical decisions have already been made: • endpoints chosen • assumptions locked • sample size underestimated • operational constraints overlooked And sometimes, the damage is irreversible. Biostatisticians are not just analysts. They are architects of scientific validity. From hypothesis formulation to study design, from power calculations to interim analyses, from SAP development to regulatory submissions — Their role is strategic. Early statistical alignment strengthens: ✔ scientific credibility ✔ ethical responsibility ✔ regulatory readiness ✔ and ultimately, patient impact In complex trial environments, statistical rigor is not a technical step. It is a leadership decision. 🔎 We explore this in depth in our latest insight: https://lnkd.in/gRqSJ3tj 👉 When do you typically involve your biostatistician in a study — and why? #Zanteris #Biostatistics #ClinicalResearch #ClinicalTrials #ClinicalOperations #EvidenceBasedMedicine #LifeSciences #DrugDevelopment #ClinicalProjectManager #UnlockClinicalExcellence